Incyte Announces Updated Data Demonstrating Rapid and Durabl

Data from the CITADEL program of parsaclisib in patients with follicular, marginal zone and mantle cell lymphomas were accepted as oral presentations at the 63rd American Society of Hematology Annual

Related Keywords

Georgia , United States , Taiwan , Hong Kong , Atlanta , China , Delaware , Michigan , Macau , American , Catalina Loveman , Peter Langmuir , Tycel Phillips , Christine Chiou , Jenifer Antonacci , American Society Of Hematology Annual Meeting , Rogel Cancer Center , Group Vice , Drug Administration , Eastern Cooperative Oncology Group , University Of Michigan , Exchange Commission , Division Of Hematology , American Society , Hematology Annual Meeting , New Drug Application , Treatment Naive , Group Vice President , Oncology Targeted Therapies , Primary Investigator , Associate Professor , Marginal Zone , Mantle Cell Lymphomas , Clinical Investigation , Mainland China , Looking Statements , Incyte , Nnounces , Pdated , Data , Emonstrating , Rapid , Durable , Responses , Parsaclisib , Patients , Relapsed , Refractory , Fell , Hodgkin , Lymphomas ,